Henkel AG & Co KGAA ST O.N. (0IZ8)
London Exchange · UK · prices in EUR · close of 20 Oct 2026
Key indicators
| Last close | EUR 71.60 |
|---|---|
| 52-week range | 57.40 – 75.00 |
| Return, 1 month / 3 months | +5.8% / +0.4% |
| Return, 1 year / 3 years | +12.6% / +33.9% |
| Trend | Uptrend |
| RSI (14) | 67 |
| Volatility (1 year) | 19.9% |
| Worst drawdown (1 year) | -22.9% |
| Average daily value traded | 0.33M EUR |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Henkel is a German industrial and consumer goods company based in Düsseldorf. It makes laundry and home care products, beauty and hair care brands, and adhesive technologies used in industry and crafts. Its consumer products reach households through retailers, while its adhesives serve manufacturers, builders and tradespeople in many markets around the world. The company operates across both everyday consumer brands and specialised industrial materials.
The shares are listed on the London Exchange in UK under the code 0IZ8, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Henkel AG & Co KGAA ST O.N. (0IZ8) trades on the London Exchange in UK. It last closed at EUR 71.60 on 20 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 945 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.6% and over the last three months it rose 0.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 7.5% | ||
| From 52-week high | -4.0% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.4% | ||
| 6-month return | 19.5% | ||
| 12-month return, skipping the last month | 6.4% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.9% | ||
| Liquidity | 42 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.33M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.7% |
|---|---|
| 1 month | +5.8% |
| 3 months | +0.4% |
| 6 months | +19.5% |
| 1 year | +12.6% |
| 3 years | +33.9% |
| 5 years | +17.4% |
Signals
| 50-day / 200-day average | 69.33 / 66.63 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.28 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Apr 2026 | EUR 2.0500 |
| 29 Apr 2025 | EUR 2.0200 |
| 23 Apr 2024 | EUR 1.8300 |
| 25 Apr 2023 | EUR 1.8300 |
| 5 Apr 2022 | EUR 1.8300 |
| 19 Apr 2021 | EUR 1.8300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.